WebYou are here: Companies > Opthea Limited (OPT) Opthea Limited (OPT) Circadian Technologies Limited (ASX: CIR, OTCQX: CKDXY) is an Australian biotechnology company developing diagnostics and biologic therapies for the treatment of cancer and other serious human illnesses. ... Share Price & Volume. Additional Research. Edison Investment … WebOpthea Ltd. $3.55. OPT 2.60%. Avecho Biotechnology Ltd ... Listed on ASX. NZ headquartered. Headquartered in Auckland, New Zealand ... The ratio of current share price to trailing twelve month EPS ...
Opthea (ASX:OPT) - Stock Price, News & Analysis - Simply Wall St
WebOpthea Ltd (OPT) Stock Price & News - Google Finance +$28.00 +$10.50 $13,330.25 +$60.25 +$0.68 Home OPT • ASX Opthea Ltd Follow Share $0.74 Apr 4, 7:00:00 PM … WebPrice trends tend to persist, so it's worth looking at them when it comes to a share like Opthea. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by-25.45%. As of the last closing price of AU$0.91, shares in Opthea were trading-16.57% below their 200 day moving average. sma chenor
Opthea Ltd (OPT) Stock Price & News - Google Finance
WebMELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent... WebSep 1, 2024 · Healthcare company Opthea Ltd ASX OPT has had a volatile year, but it could still be on the path to delivering substantial gains to long-term shareholders. Opthea has continued to demonstrate that its treatments are not only effective but also address a debilitating condition affecting a significant portion of the population. WebJun 15, 2024 · Opthea Limited (NASDAQ:OPT) investors should be aware of a decrease in support from the world's most elite money managers recently. Opthea Limited (NASDAQ: OPT ) was in 3 hedge funds' portfolios ... smachcards